Alkeus Pharmaceuticals, INC.
Pharmaceutical company focused on degenerative eye diseases.
Based in MA
AI Overview
With $420K in lobbying spend across 8 quarterly filings, Alkeus Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $180K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alkeus Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to the development of rare disease therapies.
Issues related to Stargardt disease and rare disease therapies.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.